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Abstract
The incidence of mental health disorders is significantly higher in individuals with a rare disease, compared to the
general population. This letter considers the possible reasons for this in terms of the many ways in which a rare
disease impacts on an individual’s life, and how these impacts can be strongly related to factors which predispose
to mental health difficulties.
Furthermore, issues surrounding mental health can also play a significant role in the process of diagnosing a rare
disease. The unusual nature of such diseases intrinsically predisposes an individual to obtain an inaccurate diagnosis
of a psychosomatic disorder, a diagnosis which can often be further complicated by the presence of genuine
psychiatric symptoms.
This letter argues that these common experiences of rare disease patients have impacts upon the way in which
their psychiatric care should be offered and managed, and that sensitivity and understanding surrounding these
issues should be considered a necessary part of effective care for rare disease patients.
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Main text
As a person with a rare disease, one way in which I view
my life is as a series of precarious balances. Balancing
the need for a clear diagnosis with the need to get on
with life. Balancing the time spent in hospitals as a pa-
tient with the time spent studying there as a medical
student. Balancing the wish to have completely honest
conversations with doctors with the worry that they will
no longer take you seriously if you do so. Rare disease
patients throughout the UK consistently report [1] that
the effects of their condition stretch vastly beyond the
medical, and have a large impact on many aspects of
their lives. When these impacts are considered in the
context of widely recognised risk factors for the develop-
ment of mental illness [2], it starts to become clear why
69% of rare disease patients report experiencing depres-
sion and 82% experience anxiety and stress [3], compared
to a combined rate of approximately 17% [4] in the gen-
eral population. However, patients with rare conditions
are also frequently misdiagnosed as having psychosomatic
illnesses [1] when their symptoms are difficult to align
with a common condition. As such, the relationship be-
tween rare diseases and mental illnesses is complex, and
the concurrent management of the two fraught with diffi-
culty for both doctor and patient. In this essay I shall de-
scribe the problems faced when rare diseases are mistaken
for psychological conditions and how this relates to the
challenges that having a rare disease poses to the mainten-
ance of good mental health.
A major barrier to a rare disease patient receiving ap-
propriate treatment is the delayed receipt of a diagnosis.
My own condition took 17 years to be confirmed, and
this is not particularly unusual. An average patient waits
for four years and sees five different doctors [1], but
some may wait decades and others will never receive a
diagnosis. This delay prevents patients from accessing
treatment and will often cause unnecessary deterioration
of their condition. One reason for such a delay is that
the patient is not recognised by primary healthcare pro-
fessionals as having a serious physical health problem. It
is common for rare disease patients to have unusual
constellations of symptoms, meaning physicians do notCorrespondence: rn357@cam.ac.uk
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recognise the underlying pathology. As such, patients
are frequently labelled as hypochondriacs, or as having a
psychosomatic disorder. For many, a note such as this
on a medical file means their complaints will never be
investigated seriously again. This problem with misdiag-
nosis is further exacerbated by the fact that many rare
disease patients may present simultaneously with symp-
toms which are psychiatric in nature, leading the doctor
to mistakenly attribute all symptoms to the genuine
mental health issue. These interactions with healthcare
professionals are often extremely upsetting to the
patient, leaving them feeling invalidated, mistrusted, and
hopeless. As such, consultations like these are a signifi-
cant source of the stress a rare disease patient can
experience whilst obtaining a diagnosis, and so can
themselves contribute to the development of mental
health problems.
Beyond these interactions with medical professionals,
the life of a patient with a rare disease can often be
stressful and unpredictable. This creates an ideal envir-
onment for the development of a mental health problem
such as depression or an anxiety disorder [2]. Most rare
disease patients regularly attend multiple clinics, often at
different hospitals and on different days, sometimes
many miles from their home [1]. For example, I regularly
attend four clinics, and have contact with three more,
sometimes travelling for over three hours to do so.
These visits require me to frequently take large amounts
of time out of my daily life; I am lucky in that, as a stu-
dent, my schedule has some flexibility. For children at
school and adults with jobs, this situation is much more
difficult. Missing large portions of school can increase
social isolation in children and may contribute to aca-
demic difficulties, whilst working adults may experience
job insecurity and loss of earnings. All these factors
increase stress and decrease quality of life.
Furthermore, the time spent on medical appointments
is not just restricted to their attendance. Co-ordination
of care between the several clinics any one individual at-
tends is usually managed by the patient themselves [1], a
role which can demand massive input of time and
energy. This management of care also extends to the
often relentless fight for funding, whether this be for the
off-label use of drugs which may prove beneficial to the
patient, or for personal care and mobility. The emotional
demands of the processes involved in obtaining funding
cannot be underestimated; the constant requests for cor-
respondence and evidence are exhausting. However,
even when all requirements are fulfilled, the result is
often still disappointing, creating a cycle of hopelessness
and futility.
A rare disease can also cause difficulties for a patient
in many aspects of their life entirely unrelated to their
medical care. Social isolation is common, as the
symptoms of rare diseases can prevent patients from
leaving the home freely, whilst mobility issues and prac-
tical difficulties can make certain activities inaccessible.
This can be compounded by the fact that an individual’s
condition is unlikely to be fully understood by those
around them, and so family and friends may be inadvert-
ently insensitive to the extent of the effects of the rare
disease on the individual’s life. The delay in diagnosis
can also mean that families have witnessed the patient’s
symptoms for many years with no medical explanation,
and so in some cases they have become accustomed to
thinking the patient is “not really ill”. This invalidation
can cause further distress for the patient, potentiating
the other impacts of their condition.
A patient’s intrinsic sense of identity may also be sig-
nificantly affected by their rare disease. They will often
have no definitive prognosis, which can contribute to
prolonged uncertainty and anxiety; 91% of rare disease
patients reported being worried about the future outlook
of their disease [3]. This makes future planning and
maintaining hope difficult. Furthermore, particularly
where a condition develops after early childhood, an
individual with a rare disease can have to adjust their
perception and expectations of themselves significantly.
In my experience, this point came when I began to use a
wheelchair. Whilst my doctors were were seeing X-rays,
nuclear bone scans, and muscle wastage, I was seeing
hobbies I could no longer participate in, exams that
would be difficult to sit, and a pile of laundry that had
just become exponentially more challenging. I had to
learn to rely on other people in a way that was uncom-
fortable and unwelcome, and re-shape my perception of
myself. For me, this has been the most challenging as-
pect of my condition to this day.
It is easier now to look at my own experiences and
focus on the good; how much of a relief it was to get a
diagnosis, how helpful my complicated care is, how well
I have adapted to the restrictions of my condition. But
my outcomes have made me one of the lucky ones, and
to focus on only the good is to miss the opportunity to
improve care for those who will experience a rare dis-
ease in the future. When you consider these different
ways in which a rare disease can impact a patient’s life,
and the self-perpetuating cycle of misdiagnosis and
psychological distress, it is not difficult to see why such
patients are affected disproportionately by mental illness.
However, it is harder to understand why this relationship
is so neglected. Only one in seven rare disease patients
say they receive sufficient psychological support [1], and
if we are to truly care for these patients, the availability
of psychological support must be a basic treatment
requirement. Perhaps more importantly, this support
must be offered in a way which doesn’t make patients
feel like they are being told that their illness is
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psychological in origin. Whilst rare diseases are so fre-
quently mistaken for psychosomatic disorders, patients
will be reluctant to do anything which may perpetuate
that view, including accepting psychological help. Until
this common misdiagnosis is addressed, “It’s not all in
my head!” will remain the common response to offers
of psychological help, and so patients will remain
unsupported.
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